These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 36914206)
1. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer. Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206 [TBL] [Abstract][Full Text] [Related]
2. Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells. Zhao T; Liu S; Ding X; Johnson EM; Hanna NH; Singh K; Sen CK; Wan J; Du H; Yan C JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35917184 [TBL] [Abstract][Full Text] [Related]
3. Rab7 GTPase controls lipid metabolic signaling in myeloid-derived suppressor cells. Ding X; Zhang W; Zhao T; Yan C; Du H Oncotarget; 2017 May; 8(18):30123-30137. PubMed ID: 28415797 [TBL] [Abstract][Full Text] [Related]
4. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients. Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215 [TBL] [Abstract][Full Text] [Related]
5. Characterization of lysosomal acid lipase in Ly6G Zhao T; Du H; Yan C Methods Cell Biol; 2024; 184():119-131. PubMed ID: 38555152 [TBL] [Abstract][Full Text] [Related]
6. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148 [TBL] [Abstract][Full Text] [Related]
7. Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis. Zhao T; Du H; Blum JS; Yan C Oncotarget; 2016 Jan; 7(2):1529-43. PubMed ID: 26625314 [TBL] [Abstract][Full Text] [Related]
8. Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/- mice. Ding X; Du H; Yoder MC; Yan C Am J Pathol; 2014 Feb; 184(2):397-408. PubMed ID: 24287405 [TBL] [Abstract][Full Text] [Related]
9. Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice. Zhao T; Du H; Ding X; Walls K; Yan C Oncogene; 2015 Apr; 34(15):1938-48. PubMed ID: 24882582 [TBL] [Abstract][Full Text] [Related]
10. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils. Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638 [TBL] [Abstract][Full Text] [Related]
11. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential. Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030 [TBL] [Abstract][Full Text] [Related]
12. Gene profile of myeloid-derived suppressive cells from the bone marrow of lysosomal acid lipase knock-out mice. Yan C; Ding X; Dasgupta N; Wu L; Du H PLoS One; 2012; 7(2):e30701. PubMed ID: 22383970 [TBL] [Abstract][Full Text] [Related]
13. Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer. Koinis F; Vetsika EK; Aggouraki D; Skalidaki E; Koutoulaki A; Gkioulmpasani M; Georgoulias V; Kotsakis A J Thorac Oncol; 2016 Aug; 11(8):1263-1272. PubMed ID: 27178984 [TBL] [Abstract][Full Text] [Related]
14. CD205 Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883 [TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624 [TBL] [Abstract][Full Text] [Related]
16. Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice. Qu P; Yan C; Blum JS; Kapur R; Du H J Immunol; 2011 Oct; 187(7):3854-66. PubMed ID: 21900179 [TBL] [Abstract][Full Text] [Related]
17. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology]. Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197 [TBL] [Abstract][Full Text] [Related]
18. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways. Kong Q; Ma M; Zhang L; Liu S; He S; Wu J; Liu B; Dong J Phytomedicine; 2023 Feb; 110():154638. PubMed ID: 36621167 [TBL] [Abstract][Full Text] [Related]
19. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer. Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671 [TBL] [Abstract][Full Text] [Related]
20. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses. Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]